Posted by Michael Wonder on 04 Aug 2021
Collecting patient reported outcomes in cancer clinical trials
3 August 2021 - To help patients with cancer learn more about how treatment may affect their quality of life, the FDA has issued draft guidance on collecting information about patient reported outcomes in cancer clinical trials.
Sponsors should use appropriate, validated tools to assess outcomes in the core areas.
